Last 175.48 TWD
Change Today +0.19 / 0.11%
Volume 75.0K
As of 2:54 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

obi pharma inc (4174) Snapshot

Open
175.00
Previous Close
175.29
Day High
175.55
Day Low
174.48
52 Week High
02/23/13 - 195.59
52 Week Low
12/12/12 - 70.50
Market Cap
24.3B
Average Volume 10 Days
283.5K
EPS TTM
-1.95
Shares Outstanding
138.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OBI PHARMA INC (4174)

Related News

No related news articles were found.

obi pharma inc (4174) Related Businessweek News

No Related Businessweek News Found

obi pharma inc (4174) Details

Optimer Biotechnology, Inc. manufactures anti-infective and immunotherapy drugs such as OPT-822. The company was founded in 2004 and is based in Taipei, Taiwan.

Founded in 2004

obi pharma inc (4174) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4174:TT 175.48 TWD +0.19

4174 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4174.
View Industry Companies
 

Industry Analysis

4174

Industry Average

Valuation 4174 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 28.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OBI PHARMA INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.